Onconetix, Inc.
ONCO
$0.81
-$0.03-3.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 645.90K | 735.30K | 815.40K | 1.22M | 1.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 645.90K | 735.30K | 815.40K | 1.22M | 1.33M |
| Cost of Revenue | 126.60K | 149.80K | 182.50K | 178.60K | 445.20K |
| Gross Profit | 519.20K | 585.40K | 632.90K | 1.05M | 881.70K |
| SG&A Expenses | 8.13M | 7.41M | 7.04M | 8.17M | 8.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.33M | 7.52M | 7.16M | 8.26M | 8.94M |
| Operating Income | -7.69M | -6.78M | -6.34M | -7.04M | -7.61M |
| Income Before Tax | -10.20M | -9.70M | -14.03M | -50.06M | -45.16M |
| Income Tax Expenses | 500.00 | 500.00 | 500.00 | -918.00K | -974.40K |
| Earnings from Continuing Operations | -10.20 | -9.70 | -14.03 | -49.14 | -44.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.20M | -9.70M | -14.03M | -49.14M | -44.18M |
| EBIT | -7.69M | -6.78M | -6.34M | -7.04M | -7.61M |
| EBITDA | -7.67M | -6.77M | -6.33M | -6.90M | -7.28M |
| EPS Basic | -200.08 | -436.71 | -369.65 | -550.39 | -237.91 |
| Normalized Basic EPS | 159.15 | 72.43 | 33.46 | -102.05 | -87.39 |
| EPS Diluted | -200.08 | -436.71 | -369.65 | -550.39 | -237.91 |
| Normalized Diluted EPS | 159.15 | 72.43 | 33.46 | -102.05 | -87.39 |
| Average Basic Shares Outstanding | 2.37M | 133.80K | 70.90K | 39.50K | 11.40K |
| Average Diluted Shares Outstanding | 2.37M | 133.80K | 70.90K | 39.50K | 11.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |